Jump to content

Cardiomyopathy

From Wikipedia
cardiomyopathy
clinical sign, type of disease
Subclass ofheart disease, muscular disease Edit
Health specialtycardiology Edit
Drug or therapy used for treatmentivabradine, sacubitril/valsartan Edit
Genetic associationPLN, TTR, MYBPC3, TTN Edit
WordLift URLhttp://data.medicalrecords.com/medicalrecords/healthwise/cardiomyopathy Edit
ICD-9-CM425.9, 425, 425.4 Edit

Cardiomyopathy be a group of primary diseases of de heart muscle.[1] Early on der fi be few anaa no symptoms.[1] As de disease dey worsen, shortness of breath, feeling tired, den swelling of de legs fi occur, secof de onset of heart failure.[1] An irregular heart beat den fainting fi occur.[1] Those affected be at an increased risk of sudden cardiac death.[2]

As of 2013, cardiomyopathies be defined as "disorders characterized by morphologically den functionally abnormal myocardium insyd de absence of any oda disease wey be sufficient, by einself, to cause de observed phenotype."[3][4] Types of cardiomyopathy dey include hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular dysplasia, den Takotsubo cardiomyopathy (broken heart syndrome).[5] Insyd hypertrophic cardiomyopathy de heart muscle dey enlarge den dey thicken.[5] Insyd dilated cardiomyopathy de ventricles enlarge den weaken.[5] Insyd restrictive cardiomyopathy de ventricle dey stiffen.[5]

Insyd many cases, de cause no be determined.[6] Hypertrophic cardiomyopathy usually be inherited, whereas dilated cardiomyopathy be inherited insyd about one third of cases.[6] Dilated cardiomyopathy sanso fi result from alcohol, heavy metals, coronary artery disease, cocaine abuse, den viral infections.[6] Restrictive cardiomyopathy fi be caused by amyloidosis, hemochromatosis, den sam cancer treatments.[6] Broken heart syndrome be caused by extreme emotional anaa physical stress.[5]

Treatment dey depend on de type of cardiomyopathy den de severity of symptoms.[7] Treatments fi include lifestyle changes, medications, anaa surgery.[7] Surgery fi include a ventricular assist device anaa heart transplant.[7] Insyd 2015 cardiomyopathy den myocarditis affect 2.5 million people.[8] Insyd a recent nationwide study of cardiomyopathies between 2004 den 2023, de overall prevalence more dan doubled over de two decades, plus an age-standardized prevalence of 5 insyd 1,000 insyd men, den 3 insyd 1,000 women insyd 2023. Na dilated cardiomyopathy be de most common subtype (3 insyd 1,000 for men, 1 insyd 1,000 insyd women), followed by hypertrophic cardiomyopathy (about 1 insyd 1,000 for men, 0.5 insyd 1,000 for women).[9] Insyd dis investigation, cardiomyopathies be associated plus a substantial excess mortality dem compare plus de general population, wey dey range from a 32-fold den 16-fold increase insyd de youngest men den women plus cardiomyopathies, to a two-fold increase insyd de oldest patients.[9]

References

[edit | edit source]
  1. 1 2 3 4 "What Are the Signs and Symptoms of Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
  2. ↑ "Who Is at Risk for Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 16 August 2016. Retrieved 31 August 2016.
  3. ↑ Harrison's principles of internal medicine (21st ed.). New York: McGraw Hill. 2022. p. 1954. ISBN 978-1-264-26850-4.
  4. ↑ Arbustini, Eloisa; Narula, Navneet; Dec, G. William; Reddy, K. Srinath; Greenberg, Barry; Kushwaha, Sudhir; Marwick, Thomas; Pinney, Sean; Bellazzi, Riccardo; Favalli, Valentina; Kramer, Christopher; Roberts, Robert; Zoghbi, William A.; Bonow, Robert; Tavazzi, Luigi (3 December 2013). "The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy". Journal of the American College of Cardiology (in English). 62 (22): 2046–2072. doi:10.1016/j.jacc.2013.08.1644. PMID 24263073. S2CID 43240625. Archived from the original on 19 May 2024. Retrieved 16 November 2023.
  5. 1 2 3 4 5 "Types of Cardiomyopathy". NHLBI. 22 June 2016. Archived from the original on 28 July 2016. Retrieved 31 August 2016.
  6. 1 2 3 4 "What Causes Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
  7. 1 2 3 "How Is Cardiomyopathy Treated?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
  8. ↑ GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (8 October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
  9. 1 2 Lindholm, Daniel; Ribom, Gustav; Gustafsson, Stefan; Pol, Tymon; Sundström, Johan (2026-02-05). "Cardiomyopathies: Nationwide Trends in Prevalence, Incidence, and Mortality (2004-2023)". JACC (in English). 87 (8): 1087–1090. doi:10.1016/j.jacc.2025.12.009. PMID 41603822.

Read further

[edit | edit source]
[edit | edit source]
Dem retrieve am from "https://gpe.wikipedia.org/w/index.php?title=Cardiomyopathy&oldid=111501"